PMV Pharmaceuticals Ownership | Who Owns PMV Pharmaceuticals?

PMV Pharmaceuticals Ownership Summary

PMV Pharmaceuticals is owned by 28.07% institutional investors, 3.30% insiders, and 68.63% retail investors. Orbimed advisors is the largest institutional shareholder, holding 11.49% of PMVP shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.94% of its assets in PMV Pharmaceuticals shares.

PMVP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	PMV Pharmaceuticals	28.07%	3.30%	68.63%
Sector	Healthcare Stocks	232.52%	10.72%	-143.24%
Industry	Biotech Stocks	384.56%	10.59%	-295.14%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Orbimed advisors	5.98M	11.49%	$8.37M
Bml capital management	5.29M	9.99%	$6.62M
Tang capital management	4.79M	9.20%	$6.70M
Arrowmark colorado	3.30M	6.35%	$4.62M
Sio capital management	2.64M	5.07%	$3.69M
Euclidean capital	2.63M	5.05%	$3.68M
Vanguard group	2.17M	4.10%	$2.71M
Acadian asset management	2.02M	3.80%	$2.52M
Stonepine capital management	1.37M	2.63%	$1.92M
Blackrock	1.16M	2.26%	$1.88M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bml capital management	5.29M	5.72%	$6.62M
Stonepine capital management	1.37M	1.56%	$1.92M
Euclidean capital	2.63M	1.55%	$3.68M
Sio capital management	2.64M	0.93%	$3.69M
Aldebaran capital	477.99K	0.54%	$597.49K
Tang capital management	4.79M	0.26%	$6.70M
Orbimed advisors	5.98M	0.20%	$8.37M
Arrowmark colorado	3.30M	0.09%	$4.62M
Rangeley capital	45.50K	0.06%	$63.70K
Velan capital investment management lp	35.00K	0.05%	$49.00K

Top Buyers

Holder	Shares	% Assets	Change
Tang capital management	4.79M	0.26%	4.79M
Marshall wace, llp	612.63K	0.00%	612.63K
Stonepine capital management	1.37M	1.56%	524.17K
Northern trust	380.81K	0.00%	265.16K
Boothbay fund management	201.50K	0.00%	201.50K

Top Sellers

Holder	Shares	% Assets	Change
Pfm health sciences, lp	-	-	-3.30M
Alkeon capital management	-	-	-2.34M
Blackrock	1.16M	-	-1.95M
Sio capital management	2.64M	0.93%	-1.10M
Bank of america corp /de/	340.39K	-	-1.03M

New Positions

Holder	Shares	% Assets	Change	Value
Tang capital management	4.79M	0.26%	4.79M	$6.70M
Marshall wace, llp	612.63K	0.00%	612.63K	$857.68K
Boothbay fund management	201.50K	0.00%	201.50K	$282.10K
Ikarian capital	97.50K	0.01%	97.50K	$136.50K
Algert global	62.02K	0.00%	62.02K	$87.00K

Sold Out

Holder	Change
Sbi securities	-1.00
Nelson, van denburg & campbell wealth management group	-8.00
Caitong asset management	-20.00
Nisa investment advisors	-105.00
Raymond james financial	-200.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	28	-55.56%	14,874,571	-60.33%	28	0.54%	13	-61.76%	10	-33.33%
Sep 30, 2025	60	22.45%	37,409,485	11.18%	71	1.72%	31	93.75%	15	-21.05%
Jun 30, 2025	53	-5.36%	34,682,029	-7.07%	66	1.29%	19	90.00%	20	-35.48%
Mar 31, 2025	6	-91.67%	13,804,026	-64.57%	26	0.47%	2	-90.48%	1	-96.77%
Dec 31, 2024	23	-69.33%	12,134,994	-68.90%	23	0.41%	7	-75.00%	8	-72.41%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.52M	2.94%	-
Vanguard Total Stock Mkt Idx Inv	1.49M	2.82%	-32.61K
Meridian Small Cap Growth Legacy	1.26M	2.42%	-
ArrowMark Small Cap Gro	1.26M	2.42%	-
ACAP Strategic A	1.15M	2.16%	-
SQUAD Aguja Opportunities I	570.00K	1.08%	-
Vanguard Institutional Extnd Mkt Idx Tr	371.20K	0.70%	-169.15K
BlackRock Advantage Small Cap Core Instl	280.44K	0.53%	-
Goldman Sachs Small Cp Val Insghts Instl	249.01K	0.48%	-
Fidelity Extended Market Index	209.22K	0.39%	-1.72K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 23, 2025	ORBIMED ADVISORS LLC	-	Sell	$1.52M
Sep 10, 2025	ORBIMED ADVISORS LLC	-	Sell	$900.00K
Jul 01, 2025	Ticktin Robert	General Counsel & COO	Sell	$24.65K
Jul 01, 2025	Jalota Deepika	Chief Development Officer	Sell	$35.20K
Jul 01, 2025	Carulli Michael	Chief Financial Officer	Sell	$30.08K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	1
2025 Q3	-	5
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-

PMVP Ownership FAQ

Who Owns PMV Pharmaceuticals?

PMV Pharmaceuticals shareholders are primarily institutional investors at 28.07%, followed by 3.30% insiders and 68.63% retail investors. The average institutional ownership in PMV Pharmaceuticals's industry, Biotech Stocks , is 384.56%, which PMV Pharmaceuticals falls below.

Who owns the most shares of PMV Pharmaceuticals?

PMV Pharmaceuticals’s largest shareholders are Orbimed advisors (5.98M shares, 11.49%), Bml capital management (5.29M shares, 9.99%), and Tang capital management (4.79M shares, 9.20%). Together, they hold 30.68% of PMV Pharmaceuticals’s total shares outstanding.

Does Blackrock own PMV Pharmaceuticals?

Yes, BlackRock owns 2.26% of PMV Pharmaceuticals, totaling 1.16M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.88M$. In the last quarter, BlackRock decreased its holdings by -1.948M shares, a -62.63% change.

Who is PMV Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bml capital management is PMV Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.72% of its assets in 5.29M PMV Pharmaceuticals shares, valued at 6.62M$.

Who is the top mutual fund holder of PMV Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of PMV Pharmaceuticals shares, with 2.94% of its total shares outstanding invested in 1.52M PMV Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools